Drug Profile
Estradiol cipionate/medroxyprogesterone - Pfizer
Alternative Names: Cyclofem; CycloProvera™; Esprova™; Estradiol cypionate/medroxyprogesterone - Pharmacia; Lunella; Lunelle™; MPA/E2CLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Estradiol congeners; Estrenes; Injectable contraceptives
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 05 Feb 2015 Launched for Contraception/Pregnancy (Prevention) in Argentina and Hong Kong (IM) before February 2015
- 05 Feb 2015 Withdrawn for Contraception/Pregnancy (Prevention) in USA, Chile and Indonesia (IM) before February 2015
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer